Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kelly

Showing results (341-350 of 411) with videos related to

Pageof 42
Sort By:
The Lancet. Microbe|March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control studyMosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.
Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurveyMohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
American Journal of Ophthalmology|April 25, 2024
Prevalence, Patterns, and Predictors of SARS-CoV-2 RNA and Culturable Virus in Tears of a Case-Ascertained Household CohortMatthew So, Sarah A Goldberg, Scott Lu, et al.
BMJ Global Health|November 12, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurveyMohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID SymptomsAmanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
Open Forum Infectious Diseases|August 28, 2023
Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron EraSarah A Goldberg, Scott Lu, Miguel Garcia-Knight, et al.
Mbio|September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global SpreadLisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
JCI Insight|April 7, 2022
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infectionMatthew S Durstenfeld, Michael J Peluso, J Daniel Kelly, et al.
Journal of Medical Virology|November 21, 2023
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptomsAmanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
The Journal of Infectious Diseases|October 22, 2021
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionMichael J Peluso, Scott Lu, Alex F Tang, et al.
Pageof 42

Showing results (341-350 of 411) with videos related to

Sort By:
Pageof 42
The Lancet. Microbe|March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control studyMosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.
Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurveyMohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
American Journal of Ophthalmology|April 25, 2024
Prevalence, Patterns, and Predictors of SARS-CoV-2 RNA and Culturable Virus in Tears of a Case-Ascertained Household CohortMatthew So, Sarah A Goldberg, Scott Lu, et al.
BMJ Global Health|November 12, 2021
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurveyMohamed Bailor Barrie, Sulaiman Lakoh, J Daniel Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID SymptomsAmanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
Open Forum Infectious Diseases|August 28, 2023
Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron EraSarah A Goldberg, Scott Lu, Miguel Garcia-Knight, et al.
Mbio|September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global SpreadLisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
JCI Insight|April 7, 2022
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infectionMatthew S Durstenfeld, Michael J Peluso, J Daniel Kelly, et al.
Journal of Medical Virology|November 21, 2023
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptomsAmanda M Buck, Amelia N Deitchman, Saki Takahashi, et al.
The Journal of Infectious Diseases|October 22, 2021
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionMichael J Peluso, Scott Lu, Alex F Tang, et al.
Pageof 42